Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: No. 2 Rongyang 1st Road, Xishan Economic Zone, Wuxi City, Jiangsu Province, P. R. China 214191

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    Mycophenolate Mofetil capsules 250mg
    Currently approved by the US FDA ANDA No.: 214079
    Passed the FDA on-site inspection in September 2023. On May 21, 2024, the company received the PAI EIR report sent by the FDA in an encrypted format, which stated that the company has the conditions to apply for commercial production of the product. This is the third time the company has passed the FDA on-site inspection. The entire ANDA project was approved for marketing in early November 2024.

Send your message to this supplier
  • From:
  • To:
    BRIMED
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service